Thursday, October 21, 2021

Serum Institute of India

Editorial: Double the vaccination rate

More than half of the adult population has yet to receive even a single dose, despite a slight improvement in coverage in July

Editorial: Vaccine target off the mark

As against 86 lakh doses that need to be administered per day, the vaccination rate has been just 40 lakh a day over the past week

Editorial: Expand the vaccine basket

The Centre must speed up negotiations with foreign companies towards the removal of stumbling blocks to expand coverage

SII begins manufacturing Covovax; to start trial in kids in July

"Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune," he shared in a tweet on Friday.

Centre places orders for 44 crore doses of Covishield & Covaxin

These 44 crore doses of COVID-19 vaccines will be delivered by their makers between August and December 2021, the Union Health Ministry said.

Adar Poonawalla exits Panacea Biotec

As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share.

Exploring all options to procure enough vaccines: KTR

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

Covishield production in full swing in Pune, says Poonawalla

India rolled out the third phase of its COVID-19 vaccination drive for those in the age group of 18-45 years on Saturday.

Serum Institute of India refunds South Africa for undelivered COVID-19 vaccines

A million doses from the institute, which had already been delivered, have been sold on to other countries in the African Union.

Hope to launch Covovax by September this year, says Adar Poonawalla

Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India. It has been tested against African and UK variants of COVID19 and has an overall efficacy of 89 per cent.

Thailand PM Prayuth Chan-ocha gets AstraZeneca jab

Thailand last week was the first country outside Europe to temporarily suspend using the AstraZeneca vaccine.

Chinese hackers target SII, Bharat Biotech: Report

Both SII and Bharat Biotech are involved in producing Covid-19 vaccine

NITI Aayog proposes Covid vaccine price between Rs 300-500

However, the union health ministry would take a final call on the proposition.

Ghana is first nation in world to receive COVAX vaccines

The West African nation of 30 million has recorded 81,245 cases and 584 deaths since the beginning of the pandemic, according to figures from Ghana's Health Services on Tuesday.

WHO authorises AstraZeneca’s COVID vaccine for emergency use

The coronavirus has infected more than 109 million people and killed at least 2.4 million of them.

Latest News

- Advertisement -